ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
NRC accepts Ginna SLR application as Constellation seeks 20-year extension
The Nuclear Regulatory Commission has accepted Constellation’s subsequent license renewal application to extend operations at the Ginna nuclear power plant by another 20 years.
If approved, the Ontario, N.Y., facility’s operating license would be extended through September 18, 2049. The plant was first issued a 40-year license in 1969, followed by a 20-year renewal in 2004 that extended the license into 2029.
D. Lynn Shaeffer, F. Owen Hoffman
Nuclear Technology | Volume 45 | Number 1 | August 1979 | Pages 99-106
Technical Paper | Radioactive Waste | doi.org/10.13182/NT79-A32288
Articles are hosted by Taylor and Francis Online.
An analysis was made of the uncertainty in the prediction of dose to an individual’s thyroid due to the transport of radioactive molecular iodine, 131I2, from air through the pasture-cow-milk pathway. This analysis was facilitated by the adoption of a model consisting of a multiplication of several factors represented by lognormal distributions of values. Results indicate there is a 64, 50, or 23% chance of the annual dose to an individual’s thyroid not exceeding the mean, median, or most probable doses, respectively. However, these results are tentative as a result of the limited amount of data available for annual average dose assessments. The suggestion is made that consideration be given to adopting a probabilistic approach to determining an acceptable probability of an individual receiving a dose that exceeds a limiting value.